Ropes & Gray represented Pfizer, Inc. in its entry into a definitive agreement to acquire Biohaven Pharmaceuticals, the maker of NURTEC ODT, an innovative dual-acting migraine therapy approved for both acute treatment and episodic prevention of migraine in adults ...
Ropes & Gray was awarded “Behavioral Matter of the Year” at the 2022 Global Competition Review Awards, along with other firms, for work in connection with the United States v. Google antitrust litigation.
Past events: 2020 • 2019 • 2018 Please join Boston College Law School and Ropes & Gray at our 4th Annual International IP Summit. The summit is a premier forum for practitioners, business leaders, academics, and government officials to ...
